Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Targos Molecular Pathology
Kassel, Hesse, Germany
- Ownership
- Private
- Employees
- ~65
- Development stage
- Other
01
Overview
Targos provides highly standardized clinical biomarker and molecular pathology services (IHC, ISH, mutation analysis, etc.) to support global drug development, companion diagnostics, and clinical trials for oncology and other indications, now operating within Discovery Life Sciences’ global tissue biomarker services division.
- Industry
- Contract Research Organization
02
Partnerships
Roche/GenentechBoehringer IngelheimMerck KGaAAgilent (DAKO)VentanaThermo Fisher ScientificAbbott
Beyond the preview
Go deeper on Targos Molecular Pathology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Targos Molecular Pathology.